AAPL331.34-1.74 (-0.52%) ▼|ABBV263.04+1.27 (+0.49%) ▲|ABT102.13+0.10 (+0.10%) ▲|ACN189.09-4.31 (-2.23%) ▼|ADBE252.24-5.52 (-2.14%) ▼|AMAT424.00+2.83 (+0.67%) ▲|AMD520.51+16.31 (+3.23%) ▲|AMGN376.55+0.90 (+0.24%) ▲|AMT177.92+0.18 (+0.10%) ▲|AMZN247.52-0.91 (-0.36%) ▼|AVGO340.00+0.73 (+0.22%) ▲|AXP315.02-9.38 (-2.89%) ▼|BA209.91+0.26 (+0.12%) ▲|BAC58.46-1.03 (-1.73%) ▼|BKNG170.53-0.79 (-0.46%) ▼|BLK1,056.53-1.50 (-0.14%) ▼|BMY64.06+0.30 (+0.47%) ▲|BNY153.36-1.31 (-0.85%) ▼|BRK-B519.13+2.71 (+0.52%) ▲|C134.69-1.50 (-1.10%) ▼|CAT787.57+4.68 (+0.60%) ▲|CL87.42+0.39 (+0.45%) ▲|CMCSA24.29-0.13 (-0.53%) ▼|COF203.82-2.92 (-1.41%) ▼|COP136.45-4.78 (-3.38%) ▼|COST899.50-1.85 (-0.21%) ▼|CRM253.59-2.24 (-0.88%) ▼|CSCO110.66+0.59 (+0.53%) ▲|CVS93.97-0.51 (-0.54%) ▼|CVX213.80-3.93 (-1.80%) ▼|DE681.48-2.43 (-0.35%) ▼|DHR211.77+2.48 (+1.19%) ▲|DIS107.30+0.91 (+0.86%) ▲|DUK118.21+0.47 (+0.39%) ▲|EMR146.71-0.25 (-0.17%) ▼|FDX301.79-6.54 (-2.12%) ▼|GD357.30-1.33 (-0.37%) ▼|GE310.37+3.27 (+1.06%) ▲|GEV894.97+12.80 (+1.45%) ▲|GILD147.19+0.89 (+0.60%) ▲|GM84.59-0.78 (-0.91%) ▼|GOOG341.17-0.26 (-0.08%) ▼|GOOGL344.80-0.18 (-0.05%) ▼|GS968.87-7.64 (-0.78%) ▼|HD306.74+1.20 (+0.39%) ▲|HON205.53+2.09 (+1.02%) ▲|IBM241.89-6.51 (-2.62%) ▼|INTC104.17+7.03 (+7.24%) ▲|INTU322.08-7.19 (-2.18%) ▼|ISRG379.05+1.89 (+0.50%) ▲|JNJ267.80+0.92 (+0.34%) ▲|JPM351.04-2.58 (-0.73%) ▼|KO88.43-0.27 (-0.30%) ▼|LIN465.47+2.51 (+0.54%) ▲|LLY1,145.46+8.48 (+0.75%) ▲|LMT532.13-1.34 (-0.25%) ▼|LOW195.65+1.09 (+0.56%) ▲|LRCX272.65+1.78 (+0.66%) ▲|MA568.94-4.20 (-0.73%) ▼|MCD250.59-2.32 (-0.92%) ▼|MDLZ62.30+0.20 (+0.32%) ▲|MDT94.02+0.21 (+0.22%) ▲|META682.00+11.76 (+1.75%) ▲|MMM165.71+1.05 (+0.63%) ▲|MO70.23+0.42 (+0.60%) ▲|MRK144.23+0.44 (+0.31%) ▲|MS205.64-0.61 (-0.30%) ▼|MSFT493.90-3.22 (-0.65%) ▼|MU927.22-0.39 (-0.04%) ▼|NEE81.37+0.30 (+0.36%) ▲|NFLX77.55-0.35 (-0.45%) ▼|NKE36.41+0.19 (+0.52%) ▲|NOW139.61-2.26 (-1.59%) ▼|NVDA213.97+1.80 (+0.85%) ▲|ORCL142.63+2.26 (+1.61%) ▲|PEP135.72+0.22 (+0.16%) ▲|PFE27.63+0.09 (+0.31%) ▲|PG147.26+0.60 (+0.41%) ▲|PLTR170.95-1.62 (-0.94%) ▼|PM194.62+0.61 (+0.31%) ▲|QCOM189.53+1.73 (+0.92%) ▲|RTX195.43-0.08 (-0.04%) ▼|SBUX98.02+1.44 (+1.49%) ▲|SCHW106.52-1.28 (-1.19%) ▼|SO86.57+0.62 (+0.72%) ▲|SPG205.07+0.91 (+0.45%) ▲|T26.79+0.06 (+0.21%) ▲|TMO645.60+4.12 (+0.64%) ▲|TMUS180.19-0.28 (-0.16%) ▼|TSLA358.59+2.01 (+0.56%) ▲|TXN265.97+2.54 (+0.96%) ▲|UBER70.95-0.54 (-0.76%) ▼|UNH378.37+2.43 (+0.65%) ▲|UNP283.86-0.17 (-0.06%) ▼|UPS100.67-1.71 (-1.67%) ▼|USB61.31-0.94 (-1.50%) ▼|V373.93-1.75 (-0.46%) ▼|VZ51.39-0.06 (-0.12%) ▼|WFC88.25-1.48 (-1.64%) ▼|WMT107.91-0.19 (-0.17%) ▼|XOM166.15-3.12 (-1.84%) ▼|AAPL331.34-1.74 (-0.52%) ▼|ABBV263.04+1.27 (+0.49%) ▲|ABT102.13+0.10 (+0.10%) ▲|ACN189.09-4.31 (-2.23%) ▼|ADBE252.24-5.52 (-2.14%) ▼|AMAT424.00+2.83 (+0.67%) ▲|AMD520.51+16.31 (+3.23%) ▲|AMGN376.55+0.90 (+0.24%) ▲|AMT177.92+0.18 (+0.10%) ▲|AMZN247.52-0.91 (-0.36%) ▼|AVGO340.00+0.73 (+0.22%) ▲|AXP315.02-9.38 (-2.89%) ▼|BA209.91+0.26 (+0.12%) ▲|BAC58.46-1.03 (-1.73%) ▼|BKNG170.53-0.79 (-0.46%) ▼|BLK1,056.53-1.50 (-0.14%) ▼|BMY64.06+0.30 (+0.47%) ▲|BNY153.36-1.31 (-0.85%) ▼|BRK-B519.13+2.71 (+0.52%) ▲|C134.69-1.50 (-1.10%) ▼|CAT787.57+4.68 (+0.60%) ▲|CL87.42+0.39 (+0.45%) ▲|CMCSA24.29-0.13 (-0.53%) ▼|COF203.82-2.92 (-1.41%) ▼|COP136.45-4.78 (-3.38%) ▼|COST899.50-1.85 (-0.21%) ▼|CRM253.59-2.24 (-0.88%) ▼|CSCO110.66+0.59 (+0.53%) ▲|CVS93.97-0.51 (-0.54%) ▼|CVX213.80-3.93 (-1.80%) ▼|DE681.48-2.43 (-0.35%) ▼|DHR211.77+2.48 (+1.19%) ▲|DIS107.30+0.91 (+0.86%) ▲|DUK118.21+0.47 (+0.39%) ▲|EMR146.71-0.25 (-0.17%) ▼|FDX301.79-6.54 (-2.12%) ▼|GD357.30-1.33 (-0.37%) ▼|GE310.37+3.27 (+1.06%) ▲|GEV894.97+12.80 (+1.45%) ▲|GILD147.19+0.89 (+0.60%) ▲|GM84.59-0.78 (-0.91%) ▼|GOOG341.17-0.26 (-0.08%) ▼|GOOGL344.80-0.18 (-0.05%) ▼|GS968.87-7.64 (-0.78%) ▼|HD306.74+1.20 (+0.39%) ▲|HON205.53+2.09 (+1.02%) ▲|IBM241.89-6.51 (-2.62%) ▼|INTC104.17+7.03 (+7.24%) ▲|INTU322.08-7.19 (-2.18%) ▼|ISRG379.05+1.89 (+0.50%) ▲|JNJ267.80+0.92 (+0.34%) ▲|JPM351.04-2.58 (-0.73%) ▼|KO88.43-0.27 (-0.30%) ▼|LIN465.47+2.51 (+0.54%) ▲|LLY1,145.46+8.48 (+0.75%) ▲|LMT532.13-1.34 (-0.25%) ▼|LOW195.65+1.09 (+0.56%) ▲|LRCX272.65+1.78 (+0.66%) ▲|MA568.94-4.20 (-0.73%) ▼|MCD250.59-2.32 (-0.92%) ▼|MDLZ62.30+0.20 (+0.32%) ▲|MDT94.02+0.21 (+0.22%) ▲|META682.00+11.76 (+1.75%) ▲|MMM165.71+1.05 (+0.63%) ▲|MO70.23+0.42 (+0.60%) ▲|MRK144.23+0.44 (+0.31%) ▲|MS205.64-0.61 (-0.30%) ▼|MSFT493.90-3.22 (-0.65%) ▼|MU927.22-0.39 (-0.04%) ▼|NEE81.37+0.30 (+0.36%) ▲|NFLX77.55-0.35 (-0.45%) ▼|NKE36.41+0.19 (+0.52%) ▲|NOW139.61-2.26 (-1.59%) ▼|NVDA213.97+1.80 (+0.85%) ▲|ORCL142.63+2.26 (+1.61%) ▲|PEP135.72+0.22 (+0.16%) ▲|PFE27.63+0.09 (+0.31%) ▲|PG147.26+0.60 (+0.41%) ▲|PLTR170.95-1.62 (-0.94%) ▼|PM194.62+0.61 (+0.31%) ▲|QCOM189.53+1.73 (+0.92%) ▲|RTX195.43-0.08 (-0.04%) ▼|SBUX98.02+1.44 (+1.49%) ▲|SCHW106.52-1.28 (-1.19%) ▼|SO86.57+0.62 (+0.72%) ▲|SPG205.07+0.91 (+0.45%) ▲|T26.79+0.06 (+0.21%) ▲|TMO645.60+4.12 (+0.64%) ▲|TMUS180.19-0.28 (-0.16%) ▼|TSLA358.59+2.01 (+0.56%) ▲|TXN265.97+2.54 (+0.96%) ▲|UBER70.95-0.54 (-0.76%) ▼|UNH378.37+2.43 (+0.65%) ▲|UNP283.86-0.17 (-0.06%) ▼|UPS100.67-1.71 (-1.67%) ▼|USB61.31-0.94 (-1.50%) ▼|V373.93-1.75 (-0.46%) ▼|VZ51.39-0.06 (-0.12%) ▼|WFC88.25-1.48 (-1.64%) ▼|WMT107.91-0.19 (-0.17%) ▼|XOM166.15-3.12 (-1.84%) ▼|
18.7 C
New York
Wednesday, September 16, 2026

Tag: update

ProQR Announces CTA Submission for Phase 1 Study of AX-0810 Targeting NTCP

LEIDEN, Netherlands & CAMBRIDGE, Mass., June 26, 2025 (GLOBE NEWSWIRE) -- ProQR Therapeutics NV (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies based on its proprietary Axiomer™ RNA editing technology platform, today announced the submission of a Clinical Trial Application (CTA) to the European Medicines Agency (EMA) to initiate a Phase 1 clinical trial of its lead pipeline program AX-0810 targeting NTCP, a liver cell protein that transports bile acids into cells. AX-0810 is an investigational ADAR-mediated RNA editing oligonucleotide (EON) designed to selectively modulate NTCP function by reducing toxic bile acid accumulation in the liver, potentially mitigating inflammation, fibrosis, and progression toward liver failure, which are common in cholestatic diseases.

TOP Ships Announces Approval of Listing on the Nasdaq Capital Market for Spin-Off of Rubico Inc.

ATHENS, Greece, June 26, 2025 (GLOBE NEWSWIRE) -- TOP Ships Inc. (the “Company” or “TOP Ships”) (NYSE American: TOPS), an international owner and operator of modern, fuel-efficient “ECO” tanker vessels, announced today that the application of Rubico Inc. (“Rubico”), to list its common shares on the Nasdaq Capital Market has been approved. In addition, the registration statement on Form 20-F filed by Rubico in connection with its spin-off from Top Ships Inc has been declared effective by the U.S. Securities and Exchange Commission (the “SEC”).

Ahold Delhaize USA Services, LLC Provides Update on Cybersecurity Issue

SALISBURY, N.C., June 26, 2025 (GLOBE NEWSWIRE) -- Ahold Delhaize USA Services today announced an update about the cybersecurity issue that was previously disclosed last year.

Teva Releases Q2 2025 Aide Memoire

TEL AVIV, Israel, June 26, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that its Q2 2025 Aide Memoire is available on the “Investors” page on its website.

MATSON INCREASES QUARTERLY DIVIDEND TO $0.36 PER SHARE

HONOLULU, June 26, 2025 /PRNewswire/ -- The Board of Directors of Matson, Inc. (NYSE: MATX), a leading U.S. carrier in the Pacific, has declared...

Grocery Outlet Announces Board Refreshment

Adds Two New Independent Directors with Relevant Expertise to Support Next Chapter of Growth

Kandal M Venture Limited Announces Closing of Initial Public Offering

New York, June 26, 2025 (GLOBE NEWSWIRE) -- Kandal M Venture Limited (Nasdaq: FMFC) (the “Company”), a contract manufacturer of affordable luxury leather goods with manufacturing operations in Cambodia, today announced the closing of its initial public offering (the “Offering”) of 2,000,000 Class A ordinary shares (the “Class A Ordinary Shares”) at a public offering price of $4.00 per share (the “Offering Price”). The Class A Ordinary Shares began trading on the Nasdaq Capital Market on June 25, 2025, under the symbol “FMFC.”

Marksmen Energy Inc. Announces Filing of its Q1 Interim Financial Statements

CALGARY, ALBERTA, June 26, 2025 (GLOBE NEWSWIRE) -- Marksmen Energy Inc. ("Marksmen" or the "Company") is providing this announcement further to its news releases dated May 15 and 29, June 12 and 16, 2025, with respect to the Alberta Securities Commission ("ASC") having issued a management cease trade order ("MCTO") to Marksmen pursuant to its application under National Policy 12-203 Management Cease Trade Orders ("NP 12-203") in respect of the default regarding the delay of the filing of its annual financial statements, accompanying management’s discussion and analysis and related chief executive officer ("CEO") and chief financial officer ("CFO") certifications for the financial year ended December 31, 2024 (collectively, the "Annual Filings").

Arizona Metals Corp Announces Results of 2025 Annual and Special Meeting of Shareholders

/NOT FOR DISTRIBUTION TO US NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR...

Aetherium Acquisition Corp. Announces Additional Change of Special Meeting Date

GREENWICH, Conn., June 26, 2025 (GLOBE NEWSWIRE) -- Aetherium Acquisition (the “SPAC” or the “Company”), a publicly-traded special purpose acquisition company, today announced that its Special Meeting (“Meeting”), previously scheduled at 8:30 a.m. Eastern Time on June 27, 2025, has been postponed to 8:30 a.m. Eastern Time on July 7, 2025, and the redemption right deadline has been postponed to 5:00 p.m. Eastern Time on July 2, 2025.

VIZSLA SILVER CLOSES US$100M BOUGHT DEAL OFFERING

VANCOUVER, BC, June 26, 2025 /PRNewswire/ - Vizsla Silver Corp. (TSX: VZLA) (NYSE: VZLA) (Frankfurt: 0G3) ("Vizsla Silver" or the "Company") is pleased to announce...

VIZSLA SILVER CLOSES US$100M BOUGHT DEAL OFFERING

VANCOUVER, BC, June 26, 2025 /CNW/ - Vizsla Silver Corp. (TSX: VZLA) (NYSE: VZLA) (Frankfurt: 0G3) ("Vizsla Silver" or the "Company") is pleased to announce...

Everest Medicines to Host Virtual Nephrology-Focused KOL Event on June 30, 2025

SHANGHAI, June 26, 2025 (GLOBE NEWSWIRE) -- Everest Medicines (HKEX 1952.HK, “Everest”, or the “Company”), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics, today announced that it will host a virtual nephrology-focused key opinion leader (KOL) event on Monday, June 30, 2025 at 8:00 AM ET. For English speakers, please click here to register. For individuals preferring instant Chinese translation, please click here.

BGX Outlines Strategy for Expansion

Black Gold Unveils Scalable Blueprint for Illinois Basin Development
Black Gold Unveils Scalable Blueprint for Illinois Basin Development

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsUpdate